- Home
- ACHC vs TMDX Comparison
ACHC vs TMDX Comparison
Compare ACHC & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHC
- TMDX
- Stock Information
- Founded
- ACHC 2005
- TMDX 1998
- Country
- ACHC United States
- TMDX United States
- Employees
- ACHC N/A
- TMDX N/A
- Industry
- ACHC Medical Specialities
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ACHC Health Care
- TMDX Health Care
- Exchange
- ACHC Nasdaq
- TMDX Nasdaq
- Market Cap
- ACHC 2.1B
- TMDX 2.3B
- IPO Year
- ACHC N/A
- TMDX 2019
- Fundamental
- Price
- ACHC $22.64
- TMDX $127.12
- Analyst Decision
- ACHC Buy
- TMDX Buy
- Analyst Count
- ACHC 9
- TMDX 10
- Target Price
- ACHC $47.94
- TMDX $122.89
- AVG Volume (30 Days)
- ACHC 2.4M
- TMDX 1.2M
- Earning Date
- ACHC 05-12-2025
- TMDX 05-08-2025
- Dividend Yield
- ACHC N/A
- TMDX N/A
- EPS Growth
- ACHC N/A
- TMDX N/A
- EPS
- ACHC 2.04
- TMDX 1.41
- Revenue
- ACHC $3,156,417,000.00
- TMDX $488,227,000.00
- Revenue This Year
- ACHC $7.86
- TMDX $32.58
- Revenue Next Year
- ACHC $8.55
- TMDX $21.65
- P/E Ratio
- ACHC $11.10
- TMDX $90.23
- Revenue Growth
- ACHC 5.48
- TMDX 64.43
- 52 Week Low
- ACHC $20.36
- TMDX $55.00
- 52 Week High
- ACHC $82.41
- TMDX $177.37
- Technical
- Relative Strength Index (RSI)
- ACHC 40.69
- TMDX 76.52
- Support Level
- ACHC $22.30
- TMDX $118.79
- Resistance Level
- ACHC $23.58
- TMDX $130.48
- Average True Range (ATR)
- ACHC 1.21
- TMDX 4.49
- MACD
- ACHC -0.11
- TMDX -0.15
- Stochastic Oscillator
- ACHC 7.59
- TMDX 83.53
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.